Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald A Barkauskas

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
Analytica Chimica Acta|December 17, 2009
A general-purpose baseline estimation algorithm for spectroscopic dataDonald A Barkauskas, David M Rocke
Military Medicine|November 17, 2020
Deployment and Psychological Correlates of Suicide Ideation: A Prospective, Longitudinal Study of Risk and Resilience Among Combat VeteransKate A Yurgil, Donald A Barkauskas, Dewleen G Baker
Cancer|December 4, 2019
Targeting fusions for improved outcomes in oncology treatmentMina Nikanjam, Ryosuke Okamura, Donald A Barkauskas, et al.
Molecular Cancer Therapeutics|March 16, 2021
<i>BRAF</i> V600E/V600K Mutations versus Nonstandard Alterations: Prognostic Implications and Therapeutic OutcomesMina Nikanjam, Jose Tinajero, Donald A Barkauskas, et al.
European Journal of Cancer (Oxford, England : 1990)|March 21, 2021
STK11 alterations in the pan-cancer setting: prognostic and therapeutic implicationsNithya Krishnamurthy, Aaron M Goodman, Donald A Barkauskas, et al.
Analytica Chimica Acta|August 4, 2009
Analysis of MALDI FT-ICR mass spectrometry data: a time series approachDonald A Barkauskas, Scott R Kronewitter, Carlito B Lebrilla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2017
Hyperprogressors after Immunotherapy: Analysis of Genomic Alterations Associated with Accelerated Growth RateShumei Kato, Aaron Goodman, Vighnesh Walavalkar, et al.
International Journal of Cancer|September 4, 2019
Relationship between protein biomarkers of chemotherapy response and microsatellite status, tumor mutational burden and PD-L1 expression in cancer patientsMina Nikanjam, David Arguello, Zoran Gatalica, et al.
Clinical Orthopaedics and Related Research|February 23, 2012
Poor survival for osteosarcoma of the pelvis: a report from the Children's Oncology GroupMichael S Isakoff, Donald A Barkauskas, David Ebb, et al.
Oncoimmunology|September 14, 2020
Tumor mutational burden is not predictive of cytotoxic chemotherapy responseMina Nikanjam, Paul Riviere, Aaron Goodman, et al.
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Analytica Chimica Acta|December 17, 2009
A general-purpose baseline estimation algorithm for spectroscopic dataDonald A Barkauskas, David M Rocke
Military Medicine|November 17, 2020
Deployment and Psychological Correlates of Suicide Ideation: A Prospective, Longitudinal Study of Risk and Resilience Among Combat VeteransKate A Yurgil, Donald A Barkauskas, Dewleen G Baker
Cancer|December 4, 2019
Targeting fusions for improved outcomes in oncology treatmentMina Nikanjam, Ryosuke Okamura, Donald A Barkauskas, et al.
Molecular Cancer Therapeutics|March 16, 2021
<i>BRAF</i> V600E/V600K Mutations versus Nonstandard Alterations: Prognostic Implications and Therapeutic OutcomesMina Nikanjam, Jose Tinajero, Donald A Barkauskas, et al.
European Journal of Cancer (Oxford, England : 1990)|March 21, 2021
STK11 alterations in the pan-cancer setting: prognostic and therapeutic implicationsNithya Krishnamurthy, Aaron M Goodman, Donald A Barkauskas, et al.
Analytica Chimica Acta|August 4, 2009
Analysis of MALDI FT-ICR mass spectrometry data: a time series approachDonald A Barkauskas, Scott R Kronewitter, Carlito B Lebrilla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2017
Hyperprogressors after Immunotherapy: Analysis of Genomic Alterations Associated with Accelerated Growth RateShumei Kato, Aaron Goodman, Vighnesh Walavalkar, et al.
International Journal of Cancer|September 4, 2019
Relationship between protein biomarkers of chemotherapy response and microsatellite status, tumor mutational burden and PD-L1 expression in cancer patientsMina Nikanjam, David Arguello, Zoran Gatalica, et al.
Clinical Orthopaedics and Related Research|February 23, 2012
Poor survival for osteosarcoma of the pelvis: a report from the Children's Oncology GroupMichael S Isakoff, Donald A Barkauskas, David Ebb, et al.
Oncoimmunology|September 14, 2020
Tumor mutational burden is not predictive of cytotoxic chemotherapy responseMina Nikanjam, Paul Riviere, Aaron Goodman, et al.
Pageof 9